KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Current Assets: 2017-2025

Historic Current Assets for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to $1.8 billion.

  • Amneal Pharmaceuticals' Current Assets rose 21.49% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 21.49%. This contributed to the annual value of $1.6 billion for FY2024, which is 15.24% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Current Assets stood at $1.8 billion for Q3 2025, which was up 16.01% from $1.6 billion recorded in Q2 2025.
  • Over the past 5 years, Amneal Pharmaceuticals' Current Assets peaked at $1.8 billion during Q3 2025, and registered a low of $1.3 billion during Q1 2023.
  • Over the past 3 years, Amneal Pharmaceuticals' median Current Assets value was $1.5 billion (recorded in 2024), while the average stood at $1.5 billion.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Current Assets dropped by 12.07% in 2021, and later rose by 21.49% in 2025.
  • Amneal Pharmaceuticals' Current Assets (Quarterly) stood at $1.5 billion in 2021, then dropped by 7.12% to $1.4 billion in 2022, then dropped by 2.41% to $1.4 billion in 2023, then increased by 15.24% to $1.6 billion in 2024, then grew by 21.49% to $1.8 billion in 2025.
  • Its Current Assets was $1.8 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.5 billion in Q1 2025.